杨新颖 (高级实验师)

高级实验师

性别:女

在职信息:在职

所在单位:药学院

入职时间:2005-04-05

   
当前位置: 中文主页 >> 科学研究 >> 论文成果

Structure-Based Design of 2-Aminopurine Derivatives as CDK2 Inhibitors for Triple-Negative Breast Cancer

点击次数:

所属单位:药学院

发表刊物:FRONT PHARMACOL

关键字:anticancer;CDK2 inhibitor;purine;structure-based drug design;triple-negative breast cancer

第一作者:梁翰之

论文编号:1539149221204123650

卷号:13

页面范围:864342

字数:20

是否译文:

发表时间:2022-05-03

发表时间:2022-05-03

上一条: Discovery of Novel Src Homology-2 Domain-Containing Phosphatase 2 and Histone Deacetylase Dual Inhibitors with Potent Antitumor Efficacy and Enhanced Antitumor Immunity

下一条: Boronate-Based Fluorescent Probes as a Prominent Tool for H2 O2 Sensing and Recognition